NCT03055013 2026-03-17
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Children's Oncology Group
SWOG Cancer Research Network
National Cancer Institute (NCI)